MicroRNA-124 negatively regulates LPS-induced TNF-α production in mouse macrophages by decreasing protein stability

Yang Sun1, Zhen Qin1, Qi Li1

  • 1Department of Pharmacology, School of Pharmacy, Second Military Medical University, Shanghai 200433, China.

Abstract

Insights

MicroRNA-124 (miR-124) negatively regulates the inflammatory response by targeting USP2 and USP14, reducing TNF-α production in macrophages. This finding highlights miR-124 as a potential therapeutic target for inflammation-related diseases.

Area of Science:

  • Immunology
  • Molecular Biology
  • Biochemistry

Background:

  • MicroRNAs are key regulators of immune responses.
  • Tumor necrosis factor-alpha (TNF-α) is a critical pro-inflammatory cytokine.
  • Dysregulated TNF-α production is implicated in various inflammatory diseases.

Purpose of the Study:

  • To investigate the role of microRNA-124 (miR-124) in regulating TNF-α production.
  • To elucidate the mechanism by which miR-124 affects TNF-α levels in macrophages.

Main Methods:

  • Utilized mouse macrophage cell line RAW264.7 stimulated with lipopolysaccharide (LPS).
  • Quantified miR-124 and TNF-α mRNA levels via quantitative PCR (q-PCR).
  • Assessed TNF-α protein levels using ELISA and Western blotting; analyzed miR-124 targets with 3'-UTR luciferase reporter assays.

Main Results:

  • LPS stimulation increased miR-124 levels in macrophages and mice.
  • miR-124 knockdown enhanced LPS-induced TNF-α protein production and stability.
  • miR-124 directly targets ubiquitin-specific proteases (USP) 2 and 14, which regulate TNF-α protein degradation.

Conclusions:

  • miR-124 negatively regulates LPS-induced TNF-α production in macrophages by targeting USP2 and USP14.
  • This regulatory pathway impacts TNF-α protein stability.
  • miR-124 represents a potential therapeutic target for managing inflammation-related diseases.